Terms: = Breast cancer AND SRSF2, Q01130, 6427, SFRS2
17 results:
1. Expression and prognostic role of STAT5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
2. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
3. Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database cancerCoCoPUTs for cancer-specific codon usage.
Meyer D; Kames J; Bar H; Komar AA; Alexaki A; Ibla J; Hunt RC; Santana-Quintero LV; Golikov A; DiCuccio M; Kimchi-Sarfaty C
Genome Med; 2021 Jul; 13(1):122. PubMed ID: 34321100
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes breast cancer Metastasis via Activation of FZD1.
Liu Z; Sun L; Cai Y; Shen S; Zhang T; Wang N; Wu G; Ma W; Li ST; Suo C; Hao Y; Jia WD; Semenza GL; Gao P; Zhang H
Cancer Res; 2021 Mar; 81(5):1265-1278. PubMed ID: 33402389
[TBL] [Abstract] [Full Text] [Related]
5. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
Int J Gynecol Cancer; 2019 Mar; 29(3):593-598. PubMed ID: 30821698
[TBL] [Abstract] [Full Text] [Related]
6. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract] [Full Text] [Related]
8. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract] [Full Text] [Related]
9. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
Kędzierska H; Piekiełko-Witkowska A
Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Leo F; Bartels S; Mägel L; Framke T; Büsche G; Jonigk D; Christgen M; Lehmann U; Kreipe H
Virchows Arch; 2016 Aug; 469(2):191-201. PubMed ID: 27220763
[TBL] [Abstract] [Full Text] [Related]
11. hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.
Cammas A; Lacroix-Triki M; Pierredon S; Le Bras M; Iacovoni JS; Teulade-Fichou MP; Favre G; Roché H; Filleron T; Millevoi S; Vagner S
Oncotarget; 2016 Mar; 7(13):16793-805. PubMed ID: 26930004
[TBL] [Abstract] [Full Text] [Related]
12. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract] [Full Text] [Related]
13. Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.
Workenhe ST; Ketela T; Moffat J; Cuddington BP; Mossman KL
Oncogene; 2016 May; 35(19):2465-74. PubMed ID: 26257065
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide analysis of alternative transcripts in human breast cancer.
Wen J; Toomer KH; Chen Z; Cai X
Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
[TBL] [Abstract] [Full Text] [Related]
15. Splicing factor mutations and cancer.
Yoshida K; Ogawa S
Wiley Interdiscip Rev RNA; 2014; 5(4):445-59. PubMed ID: 24523246
[TBL] [Abstract] [Full Text] [Related]
16. Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.
Sharma S; Liao W; Zhou X; Wong DT; Lichtenstein A
Mol Cancer Ther; 2011 Sep; 10(9):1751-9. PubMed ID: 21764905
[TBL] [Abstract] [Full Text] [Related]
17. An integrated physical and gene map of human distal chromosome 17q24-proximal 17q25 encompassing multiple disease loci.
Kalikin LM; George RA; Keller MP; Bort S; Bowler NS; Law DJ; Chance PF; Petty EM
Genomics; 1999 Apr; 57(1):36-42. PubMed ID: 10191081
[TBL] [Abstract] [Full Text] [Related]
